Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Anim Sci ; 96(1): 56-65, 2018 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-29385599

RESUMO

Purulent vaginal discharge (PVD) is a common uterine disease in dairy cattle that has negative effects on reproductive performance. Reproductive management programs that synchronize ovulation use gonadotropin-releasing hormone (GnRH) to induce ovulation and prostaglandin F2α (PGF2α) to induce luteolysis. The objectives of this study were to evaluate ovarian response to treatment with GnRH and the odds of bearing a corpus luteum or being inseminated in dairy cows with or without PVD. Another objective was to determine the hazard of insemination after administration of PGF2α in dairy cows with or without PVD. Primiparous (n = 291) and multiparous (n = 402) cows were evaluated for PVD using a Metricheck device at 46 ± 3 and 35 ± 3 days in milk (DIM) (study day 0), respectively. On study day 14, primiparous (n = 107) and multiparous (n = 197) cows were treated with GnRH and subsequent ovulation was recorded. Primiparous (n = 178) and multiparous (n = 368) cows not inseminated by study day 21 were administered PGF2α and response to PGF2α treatment was determined by detection of estrus. Furthermore, cows were categorized by the presence of a CL or being inseminated by study days 14, 21, and 35. Overall prevalence of PVD was 28.5% and 13.4% for primiparous and multiparous cows, respectively. Projected 305-d milk yield was less (P < 0.01) in PVD+ multiparous cows compared with PVD- multiparous cows, however, no (P = 0.26) difference was detected between primiparous PVD+ and PVD- cows. Ovulatory response to GnRH treatment was 51.8% and 47.8% for primiparous and multiparous cows, respectively. Primiparous PVD- cows tended (P = 0.06) to be less likely to ovulate to GnRH than primiparous PVD+ cows, whereas multiparous PVD+ cows were less (P = 0.04) likely to ovulate to GnRH than PVD- multiparous cows. The odds of bearing a corpus luteum or being inseminated by study days 14, 21, or 35 was not associated with PVD in primiparous cows. In contrast, the odds of bearing a corpus luteum or being inseminated by study days 14 and 21 was (P ≤ 0.03) associated with PVD in multiparous cows, but not (P = 0.11) on study day 35. Hazard of insemination after PGF2α was not (P ≥ 0.38) associated with PVD in primiparous or multiparous cows. Purulent vaginal discharge is associated with response to treatment with GnRH in dairy cattle. Purulent vaginal discharge might negatively affect reproductive management programs that use GnRH to induce ovulation.


Assuntos
Bovinos/fisiologia , Dinoprosta/farmacologia , Hormônio Liberador de Gonadotropina/farmacologia , Reprodução/efeitos dos fármacos , Descarga Vaginal/veterinária , Animais , Corpo Lúteo/efeitos dos fármacos , Estro/efeitos dos fármacos , Sincronização do Estro/efeitos dos fármacos , Feminino , Inseminação Artificial/veterinária , Lactação/efeitos dos fármacos , Luteólise/efeitos dos fármacos , Ovário/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Paridade/efeitos dos fármacos , Gravidez
3.
J Dairy Sci ; 99(9): 7612-7623, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27289155

RESUMO

The objectives of the experiments were to compare ovarian responses, pregnancy per artificial insemination, and pattern of insemination of 2 estrus detection-based presynchronization protocols before first artificial insemination (AI) during heat stress. In experiment 1, primiparous lactating dairy cows (n=1,358) from 3 dairies were assigned randomly to 2 treatments at 60±3 (±SD) DIM (study d 0): (1) treatment with 100 µg of GnRH on study d 0 (Gpresynch), or (2) no treatment on study d 0 (control). In experiment 2, multiparous lactating dairy cows (n=1,971) from 3 dairies were assigned randomly to 2 treatments at 49±3 (±SD) DIM (study d 0), similar to experiment 1. In both experiments, PGF2α injections were administered 14 d apart starting on study d 7 for all cows. Cows not inseminated after detection of estrus were submitted to a timed artificial insemination protocol at study d 35. In a subgroup of cows from 2 dairies, concentrations of progesterone were determined from blood samples collected on study d 0 and 7. Furthermore, ovaries were examined by ultrasonography on study d -14, 0, and 7 to determine cyclic status and ovulation in response to GnRH treatment. In experiment 1, progesterone concentration was not different on d 0, but progesterone was increased for Gpresynch compared with control cows on study d 7 (3.6±0.3 vs. 2.7±0.4 ng/mL), respectively. Ovulation risk from study d 0 to 7 was increased for Gpresynch compared with control (50.6 vs. 15.2%). Control cows were inseminated at a faster rate than Gpresynch cows [adjusted hazard ratio (AHR)=0.89, 95% confidence interval=0.80 to 1.00], and the interaction between treatment and dairy affected pregnancy per artificial insemination at 36 and 94 d post-artificial insemination. In experiment 2, concentrations of progesterone did not differ on study d 0 or 7, despite ovulation risk from study d 0 to 7 being greater in Gpresynch than control cows (46.9 vs. 23.8%). The interaction between treatment and dairy affected hazard of insemination with Gpresynch cows from dairy 1 (AHR=1.21; 1.05 to 1.41) being inseminated faster than control cows. Hazard of pregnancy was affected by treatment because Gpresynch cows became pregnant at a faster rate than control cows (AHR=1.25; 1.04 to 1.50). In conclusion, GnRH-based presynchronization protocols initiated before the end of the voluntary waiting period may have benefits in reproductive efficiency of estrus detection-based programs during heat stress. In addition, treatment with GnRH decreased the prevalence of anovular cows at the initiation of PGF2α injections.


Assuntos
Bovinos/fisiologia , Detecção do Estro , Hormônio Liberador de Gonadotropina/farmacologia , Inseminação Artificial/veterinária , Animais , Sincronização do Estro , Feminino , Hormônio Liberador de Gonadotropina/administração & dosagem , Temperatura Alta , Gravidez , Distribuição Aleatória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...